Recent News & Articles
To get up-to-date information on SUMO news, check out the latest articles. These articles are available online by clicking on one of the links below. You must have Adobe Reader to view most of the articles.
View By Type:
Oplinc2011-09-14 - Oplinc Fast Facts
Oplinc
2011-09-12 - Politics and Physicians Payments
ASCO
2011-04-20 - ASCO Summary of ACO Proposed Rule
On Thursday, March 31, 2011 CMS released a notice of proposed rulemaking to establish a statutorily-required Shared Savings program for Accountable Care Organizations (ACOs). The rule was published in the April 7, 2011 Federal Register. Comments are ...
Health Care
2011-04-12 - States Implement Health Reform
ASCO
2010-07-23 - CMS’s Plans for the A/B Medicare Administrative Contractor
CMS’s Plans for the A/B Medicare Administrative Contractor “Round II” Procurements: Important Information for Potential Offerors Concerning -
• Consolidation of A/B MAC Jurisdictions
• Management of the A/B MAC Marketplace
• Responsibilities of ...
• Consolidation of A/B MAC Jurisdictions
• Management of the A/B MAC Marketplace
• Responsibilities of ...
COA
2010-07-23 - Community Oncology Cancer Care Practice Impact Report
• The Community Oncology Alliance (COA) has developed a tracking database on the adverse
impact of Medicare reimbursement on community oncology practices. The database was initially
compiled from private and public sources.
• Included in this re...
impact of Medicare reimbursement on community oncology practices. The database was initially
compiled from private and public sources.
• Included in this re...
News Article
2010-06-25 - Oncology Practice Insider
It is hard not to become overwhelmed with the business of oncology practice today. Fewer resources, more patients, Medicare uncertainty are just a few of challenges we face. It is important - but frequently difficult - to keep our focus on the patien...
ASCO
2010-06-25 - Receive a FREE ASCO University Educational Module!
From oncology nurses to practice administrators to oncologists, every cancer care professional has a home at ASCO.
The American Society of Clinical Oncology knows that providing the best cancer care requires a team effort. Through multiple members...
The American Society of Clinical Oncology knows that providing the best cancer care requires a team effort. Through multiple members...
ASCO
2010-06-25 - Oncology Practice Insider
Well, it's a good news/bad news story. The good news, of course, is that we finally have a Medicare payment patch, retroactive to June 1. And more good news is that this patch includes a 2.2% increase for the next six months. But the bad news is th...
News Article
2010-06-18 - How Medicare’s Payment Cuts For Cancer Chemotherapy Drugs Changed Patterns Of Treatment
The Medicare Prescription Drug, Improvement, and
Modernization Act, enacted in 2003, substantially reduced payment rates
for chemotherapy drugs administered on an outpatient basis starting in
January 2005. We assessed how these reductions affected...
Modernization Act, enacted in 2003, substantially reduced payment rates
for chemotherapy drugs administered on an outpatient basis starting in
January 2005. We assessed how these reductions affected...
FDA Approval
2010-06-18 - FDA Approves New Treatment for Advanced Prostate Cancer
FDA Approves New Treatment for Advanced Prostate Cancer The U.S. Food and Drug Administration today approved Jevtana (cabazitaxel), a chemotherapy drug used in combination with the steroid prednisone to treat men with prostate cancer. Jevtana is the ...
FDA Approval
2010-06-18 - FDA Approves New Indication for Tasigna
FDA Approves New Indication for Tasigna Approval expands use in treatment of rare type of leukemia The U.S. Food and Drug Administration today approved a new indication for Tasigna (nilotinib) for the treatment of a rare blood cancer when it is first...
News Article
2010-06-17 - MarketWatch Does Reimbursement Influence Chemotherapy Treatment For Cancer Patients?
Does Reimbursement Influence Chemotherapy
Treatment For Cancer Patients?
Medicare reimbursement has little effect on who gets cancer
treatment, but it does influence the kind of treatment received.
by Mireille Jacobson, A. James O’Malley, Craig C...
Treatment For Cancer Patients?
Medicare reimbursement has little effect on who gets cancer
treatment, but it does influence the kind of treatment received.
by Mireille Jacobson, A. James O’Malley, Craig C...
FDA Approval
2010-06-02 - FDA Approves New Injectable Osteoporosis Treatment for Postmenopausal Women
The U.S. Food and Drug Administration today approved Prolia, an injectable treatment for postmenopausal women with osteoporosis who are at high risk for fractures.
Osteoporosis is a disease in which the bones become weak and are more likely to b...
Osteoporosis is a disease in which the bones become weak and are more likely to b...
FDA Approval
2010-05-07 - FDA Approves Drug Treatment for Rare Cancer
Cutaneous T-cell lymphoma affects about 1,500 Americans annually
The U.S. Food and Drug Administration has approved Istodax (romidepsin), an injectable medication, for treatment of patients with a rare form of cancer known as Cutaneous T-cell Lympho...
The U.S. Food and Drug Administration has approved Istodax (romidepsin), an injectable medication, for treatment of patients with a rare form of cancer known as Cutaneous T-cell Lympho...
FDA Approval
2010-04-16 - Erlotinib (Tarceva)
On April 16, 2010, the U. S. Food and Drug Administration (FDA) approved erlotinib (Tarceva) tablets for maintenance treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease has not progressed after f...
PQRI Standards for Oncology
2010-01-21 - PQRI 2010 Standards for Oncology
FDA Approval
2009-09-28 - Pralatrexate Injection (Folotyn)
: On September 24, 2009, the Office of Oncology Drug Products granted accelerated approval to pralatrexate injection (FOLOTYN, Allos Therapeutics, Inc.) for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). Th...
FDA
2009-09-16 - FDA Clears a Test for Ovarian Cancer
FDA Clears a Test for Ovarian Cancer
Test can help identify potential malignancies, guide surgical decisions
The U.S. Food and Drug Administration today cleared a test that can help detect ovarian cancer in a pelvic mass that is already known to ...
Test can help identify potential malignancies, guide surgical decisions
The U.S. Food and Drug Administration today cleared a test that can help detect ovarian cancer in a pelvic mass that is already known to ...
FDA
2009-09-16 - FDA Requires Boxed Warning for Promethazine Hydrochloride Injection
FDA Requires Boxed Warning for Promethazine Hydrochloride Injection
The U.S. Food and Drug Administration is telling manufacturers of the drug promethazine to include a boxed warning regarding the injectable form of the drug. The warning, under FDA'...
The U.S. Food and Drug Administration is telling manufacturers of the drug promethazine to include a boxed warning regarding the injectable form of the drug. The warning, under FDA'...
FDA
2009-08-21 - FDA Issues Final Rules to Help Patients Gain Access to Investigational Drugs
The U.S. Food and Drug Administration published two rules today that seek to clarify the methods available to seriously ill patients interested in gaining access to investigational drugs and biologics when they are not eligible to participate in a cl...
Medicare
2009-08-21 - Reporting Non-Tax Withholding Due to Federal Payment Levy Program (FPLP)
Reporting Non-Tax Withholding Due to Federal Payment Levy Program (FPLP)
Reference: Trans. 503, CR #6228, Pub. 100-20, MLN: MM6228
Published Online: 8/14/2009
Provider Types Affected
Physicians and providers who bill Medicare carriers, fiscal i...
Reference: Trans. 503, CR #6228, Pub. 100-20, MLN: MM6228
Published Online: 8/14/2009
Provider Types Affected
Physicians and providers who bill Medicare carriers, fiscal i...
Health Care
2009-08-21 - Reporting Non-Tax Withholding Due to Federal Payment Levy Program (FPLP)
By JONATHAN WEISMAN and NAFTALI BENDAVID
The White House and Senate Democratic leaders, seeing little chance of bipartisan support for their health-care overhaul, are considering a strategy shift that would break the legislation into two parts and p...
The White House and Senate Democratic leaders, seeing little chance of bipartisan support for their health-care overhaul, are considering a strategy shift that would break the legislation into two parts and p...
CMS Update
2009-08-07 - updated policy from CMS regarding OncotypeDX- J1 MAC
http://www.cms.hhs.gov/mcd/viewlcd.asp?lcd_id=28287&lcd_version=18&show=
FDA Approval
2009-07-31 - FDA Approval for Avastin in Combination with Interferon Alfa
Bevacizumab (Avastin) in Combination with Interferon Alfa
On July 31, 2009 the U.S. Food and Drug Administration granted approval for the use of bevacizumab (Avastin, Genentech, Inc.) in combination with interferon alfa for the treatment of patients...
On July 31, 2009 the U.S. Food and Drug Administration granted approval for the use of bevacizumab (Avastin, Genentech, Inc.) in combination with interferon alfa for the treatment of patients...
FDA Approval
2009-07-09 - FDA Approves First Maintenance Drug Therapy for Advanced Lung Cancer(Alimta)
FDA Approves First Maintenance Drug Therapy for Advanced Lung Cancer
The U.S. Food and Drug Administration has approved Alimta (pemetrexed), the first drug available for maintenance therapy of advanced or metastatic lung cancer.
The U.S. Food and Drug Administration has approved Alimta (pemetrexed), the first drug available for maintenance therapy of advanced or metastatic lung cancer.
FDA Approval
2009-07-02 - Ferumoxytol (Feraheme) Injection
The safety and efficacy of ferumoxytol in the episodic treatment of iron deficiency anemia were assessed in three randomized, open-label, controlled clinical trials enrolling approximately 800 patients with CKD. In all three controlled trials, patie...
CMS Update
2009-07-02 - Medicare Issues Severe Cuts for Community Oncology
CMS has just issued severe cuts to Medicare reimbursement, including a 6% payment cut for community cancer care and elimination of consultation codes.
The CMS cut to cancer care is based upon the flawed survey data provided to
CMS by the AMA, whic...
The CMS cut to cancer care is based upon the flawed survey data provided to
CMS by the AMA, whic...
FDA
2009-05-21 - Drug Shortages Updates
Morphine Sulfate Oral Solution updated by FDA 5/20/2009
Roxane Laboratories (20mg/5ml and 10mg/5ml) - has product available
Mallinckrodt Inc. (20mg/ml) Customer Service number (1-800-325-8888) - increased demand due to another manufacturer leav...
Roxane Laboratories (20mg/5ml and 10mg/5ml) - has product available
Mallinckrodt Inc. (20mg/ml) Customer Service number (1-800-325-8888) - increased demand due to another manufacturer leav...
FDA
2009-05-18 - Drug Shortages